First Time Loading...

Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957

Watchlist Manager
Yunnan Botanee Bio-Technology Group Co Ltd Logo
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Watchlist
Price: 61.67 CNY 1% Market Closed
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Yunnan Botanee Bio-Technology Group Co Ltd

Wall Street analysts forecast Yunnan Botanee Bio-Technology Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Yunnan Botanee Bio-Technology Group Co Ltd is 87.49 CNY with a low forecast of 60.6 CNY and a high forecast of 131.25 CNY.

Lowest Forecast
Wall Street Target
60.6 CNY
2% Downside
Average Forecast
Wall Street Target
87.49 CNY
42% Upside
Highest Forecast
Wall Street Target
131.25 CNY
113% Upside
Lowest
Price Target
60.6 CNY
2% Downside
Average
Price Target
87.49 CNY
42% Upside
Highest
Price Target
131.25 CNY
113% Upside
Yunnan Botanee Bio-Technology Group Co Ltd Competitors:
Price Targets
BEI
Beiersdorf AG
0% Downside
7806
MTG Co Ltd
12% Upside
COTY
Coty Inc
23% Upside
N
092730
NeoPharm Co Ltd
41% Upside
BEI
Beiersdorf AG
0% Downside
7806
MTG Co Ltd
12% Upside
COTY
Coty Inc
23% Upside
N
092730
NeoPharm Co Ltd
41% Upside
FTLF
FitLife Brands Inc
84% Downside
4928
Noevir Holdings Co Ltd
11% Upside
EL
Estee Lauder Companies Inc
27% Upside

Revenue
Forecast

Revenue Estimate
Yunnan Botanee Bio-Technology Group Co Ltd

For the last 4 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's revenue is 42%. The projected CAGR for the next 4 years is 18%.

42%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Yunnan Botanee Bio-Technology Group Co Ltd

For the last 4 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's operating income is 38%. The projected CAGR for the next 4 years is 19%.

38%
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Yunnan Botanee Bio-Technology Group Co Ltd

For the last 4 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's net income is 42%. The projected CAGR for the next 3 years is 20%.

42%
Past Growth
20%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Yunnan Botanee Bio-Technology Group Co Ltd's stock price target?
Price Target
87.49 CNY

According to Wall Street analysts, the average 1-year price target for Yunnan Botanee Bio-Technology Group Co Ltd is 87.49 CNY with a low forecast of 60.6 CNY and a high forecast of 131.25 CNY.

What is Yunnan Botanee Bio-Technology Group Co Ltd's Revenue forecast?
Projected CAGR
18%

For the last 4 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's revenue is 42%. The projected CAGR for the next 4 years is 18%.

What is Yunnan Botanee Bio-Technology Group Co Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 4 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's operating income is 38%. The projected CAGR for the next 4 years is 19%.

What is Yunnan Botanee Bio-Technology Group Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 4 years the compound annual growth rate for Yunnan Botanee Bio-Technology Group Co Ltd's net income is 42%. The projected CAGR for the next 3 years is 20%.

ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.